Author: OurCrowd

[Insightec in PR Newswire] Insightec Announces First Glioblastoma Patient Completed Chemotherapy Cycles With Blood Brain Barrier Disruption Using Focused Ultrasound in Yonsei University

INSIGHTEC®, a global medical technology innovator of incisionless surgery, and Yonsei University announced today that the first patient worldwide completed chemotherapy cycles in a clinical trial to investigate the safety and efficacy of focused ultrasound for disrupting the blood brain barrier (BBB) in patients with glioblastoma (GBM). Read more...

Read More